121 related articles for article (PubMed ID: 7566933)
1. [Vasoactive polypeptide-producing pancreatic carcinoma].
Gréczi K; Küronya P; Krutsay M
Orv Hetil; 1995 Sep; 136(37):2009-11. PubMed ID: 7566933
[TBL] [Abstract][Full Text] [Related]
2. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
4. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
Flückiger A; Schlup P
Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
[TBL] [Abstract][Full Text] [Related]
5. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
Shaib W; Mitchell K; Saif MW
Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
[TBL] [Abstract][Full Text] [Related]
8. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
[TBL] [Abstract][Full Text] [Related]
9. Clinical problem-solving. Needle in a haystack.
Kapoor R; Moseley RH; Kapoor JR; Crapo LM; Saint S
N Engl J Med; 2009 Feb; 360(6):616-21. PubMed ID: 19196679
[No Abstract] [Full Text] [Related]
10. Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.
Nilubol N; Freedman EM; Quezado MM; Patel D; Kebebew E
J Clin Endocrinol Metab; 2016 Oct; 101(10):3564-3567. PubMed ID: 27583474
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome.
Brunt LM; Mazoujian G; O'Dorisio TM; Wells SA
Surgery; 1994 Mar; 115(3):362-9. PubMed ID: 8128360
[TBL] [Abstract][Full Text] [Related]
13. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
Scheffold N; Arnold R; Cyran J
Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of VIPoma in a female patient.
Remme CA; de Groot GH; Schrijver G
Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):93-9. PubMed ID: 16357627
[TBL] [Abstract][Full Text] [Related]
15. Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndrome.
Brunani A; Crespi C; De Martin M; Dubini A; Piolini M; Cavagnini F
J Endocrinol Invest; 1991 Sep; 14(8):685-9. PubMed ID: 1663530
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia, type 1, with pancreatic cholera.
Namihira Y; Achord JL; Subramony C
Am J Gastroenterol; 1987 Aug; 82(8):794-7. PubMed ID: 2886044
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
18. [Mixed endocrine tumor with atypical Verner-Morrison syndrome: dissociated responses to somatostatin infusion and surgery].
Rigaud D; Cerf M; Ou-Yan C; Arrago JP; Accary JP; Chayvialle JA; René E; Bonfils S
Gastroenterol Clin Biol; 1982; 6(6-7):563-9. PubMed ID: 6126418
[No Abstract] [Full Text] [Related]
19. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
[TBL] [Abstract][Full Text] [Related]
20. Vipoma: effective treatment with octreotide in the oldest old.
Schoevaerdts D; Favet L; Zekry D; Sieber CC; Michel JP
J Am Geriatr Soc; 2001 Apr; 49(4):496-7. PubMed ID: 11347804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
